BiotechTube
Home/Revolo Biotherapeutics/Femi Oluboyede
FO

Femi Oluboyede

Vice President, Technical Operations, CMC

Revolo Biotherapeutics

Therapeutic Areas

Autoimmune DiseasesAllergic Diseases

Revolo Biotherapeutics Pipeline

DrugIndicationPhase
'1104Eosinophilic Esophagitis (EoE)Phase 2
'1805Rheumatoid ArthritisPhase 2 (Planned)

Leadership Team at Revolo Biotherapeutics

KB
Kari Brown, M.D.
Chief Medical Officer
DS
David Southwell
Chairman
JD
Jorge De Alba, Ph.D.
Vice President, Discovery and Translational Science
PE
Paul Eggleton, Ph.D.
Vice President, Immunology
MP
Maria Pittaras, PMP
Vice President, Portfolio and Program Management
View full Revolo Biotherapeutics profile